AOD-9604 vs Semaglutide AOD-9604, a modified fragment of human growth hormone (amino acids 176-191), and Semaglutide, a GLP-1 receptor agonist, represent fundamentally different approaches to fat metabolism research
Front Endocrinol (Lausanne) 12:645563 Davies M, Pieber TR, Hartoft-Nielsen ML, Hansen OKH, Jabbour S, Rosenstock J (2017) Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes: a randomized clinical trial
Interplay of epidermal growth factor receptor and signal transducer and activator of transcription 3 in prostate cancer: beyond androgen receptor transactivation
8:419-428, 2006 [ Links ] 91
The lactation safety data applies specifically to FDA-approved, pharmaceutical-grade semaglutide and tirzepatide